{"id":28802,"date":"2023-09-21T09:35:26","date_gmt":"2023-09-21T08:35:26","guid":{"rendered":"https:\/\/cannabishealthnews.co.uk\/?p=28802"},"modified":"2023-09-21T09:40:15","modified_gmt":"2023-09-21T08:40:15","slug":"new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders","status":"publish","type":"post","link":"https:\/\/cannabishealthnews.co.uk\/2023\/09\/21\/new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders\/","title":{"rendered":"New cannabis research: cancer, Type 2 diabetes, autism, fibromyalgia and skin disorders"},"content":{"rendered":"

New research suggests cannabis may go some way to reducing the risk of developing Type 2 diabetes, while other studies shed light on its potential in fibromyalgia, autism and skin disorders.<\/b><\/h3>\n

A wealth of cannabis-related research has been published over the last few months, including studies examining its potential in the treatment of fibromyalgia<\/a>, autism<\/a> and skin disorders.<\/span><\/p>\n

Meanwhile, a review suggests cannabis consumption may be associated with a reduced risk of developing Type 2 diabetes, and a US survey highlights the prevalence of use among cancer<\/a> patients.\u00a0<\/span><\/p>\n

We take a closer look.<\/span><\/p>\n

Cannabis reduces severity of fibromyalgia symptoms\u00a0<\/b><\/h4>\n

In a new study, researchers conducted a retrospective review of patients seeking medicinal cannabis treatment for fibromyalgia between January 2017- July 2021. Data was collected using the Patient Health Questionnaire-9 (PHQ-9) Generalized Anxiety Disorder-7 (GAD-7) scores, and self-reported illness severity.<\/span><\/p>\n

According to their findings, a clinically significant reduction in severity was observed in three quarters 75% of patients, as well as reductions in PHQ-9 (27%) and GAD-7 scores (22%).<\/span><\/p>\n

The authors conclude: \u201cThese data show that medical cannabis may play an important role in the management of fibromyalgia and associated symptoms of depression and anxiety.\u201d<\/span><\/p>\n

Read more here\u00a0<\/a><\/strong><\/p>\n

 <\/p>\n

Cannabis improves quality of life in autistic patients – and their families\u00a0<\/b><\/h4>\n

A new study explored the impact of full-spectrum cannabis extracts in 20 patients with autism spectrum disorders (ASD).<\/span><\/p>\n

Most patients were treated for a minimum of six\u2009months, with doses and THC\/CBD levels adjusted depending on results.\u00a0 The researchers used a novel online patient- or caregiver-reported outcome survey to collect information on core and co-morbid symptoms and quality of life.\u00a0<\/span><\/p>\n

Their retrospective analysis found that 18 out of 20 patients showed improvement in their symptoms, as well as an improved quality of life for patients and their families.\u00a0<\/span><\/p>\n

Side effects were mild and infrequent and <\/span>in most cases, other medications were able to be reduced or discontinued entirely, the researchers say.\u00a0<\/span><\/p>\n

Read more about the study here\u00a0<\/a><\/strong><\/p>\n

 <\/p>\n

Cannabis may reduce risk of developing Type 2 diabetes\u00a0<\/b><\/h4>\n

A new study has suggested that cannabis may have a protective effect against the risk of developing Type 2 diabetes.\u00a0<\/span><\/p>\n

To understand more about the effect of cannabis <\/span>on metabolism, including glucose regulation and insulin secretion, r<\/span>esearchers conducted a systematic review of previous studies in this area.\u00a0<\/span><\/p>\n

Their meta-analysis of seven studies, containing 11 surveys and four cohort studies, revealed that the odds of developing Type 2 diabetes was\u00a0 0.48 times (95%) lower than in those who had not consumed cannabis.\u00a0<\/span><\/p>\n

The authors conclude: \u201cA protective effect of cannabis consumption on the odds of diabetes mellitus type 2 development has been suggested. Yet given the considerable interstudy heterogeneity, the upward trend of cannabis consumption and cannabis legalisation is recommended to conduct studies with higher levels of evidence.\u201d<\/span><\/p>\n

Read more about the study here\u00a0<\/a><\/strong><\/p>\n

 <\/p>\n

One third of cancer patients use cannabis – but do their doctors know?<\/b><\/h4>\n

Results from a survey of over 1,200 cancer patients, show that almost a third used cannabis following their diagnosis.<\/span><\/p>\n

Patients with nine different cancers being treated at a centre in the US between March and August 2021 were surveyed on their cannabis use, as well as their attitudes and communication around it.<\/span><\/p>\n

Overall 31% used cannabis after diagnosis, ranging from 25% of those with lung cancer to 59% of patients with testicular cancer.\u00a0<\/span><\/p>\n

Reasons for cannabis use included difficulty sleeping (48%); stress, anxiety, or depression (46%); and pain (42%), with 70-90% reporting symptom improvement.\u00a0<\/span><\/p>\n

However, only 25% of those who used cannabis discussed this with their healthcare providers.<\/span><\/p>\n

Read more about the study here\u00a0<\/a><\/strong><\/p>\n

 <\/p>\n

CBD holds \u2018promise\u2019 for skin disorders<\/b><\/h4>\n

Researchers carried out a review of previous studies looking at CBD in the treatment of skin disorders such as acne, dermatitis, psoriasis, and ageing skin.\u00a0<\/span><\/p>\n

They report that the cannabinoid has \u2018potential applications\u2019 in the treatment of skin disorders, specifically those which have limited treatment options available or come with side-effects.\u00a0<\/span><\/p>\n

It may be a \u2018promising\u2019 treatment for chronic skin conditions such as psoriasis and atopic dermatitis. And as it can be used as a \u2018multifunctional ingredient\u2019 may increase patient adherence to treatment, through reducing the number of products required to manage the condition.\u00a0<\/span><\/p>\n

However, the authors add that more research is needed to establish its use in the treatment of these conditions, as well as investigating new applications and addressing the safety of topical CBD.\u00a0<\/span><\/p>\n

Read the full study here\u00a0<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

Catch up on some of the latest cannabis science.<\/p>\n","protected":false},"author":17,"featured_media":28822,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_cbd_carousel_blocks":"[]","content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_EventAllDay":false,"_EventTimezone":"","_EventStartDate":"","_EventEndDate":"","_EventStartDateUTC":"","_EventEndDateUTC":"","_EventShowMap":false,"_EventShowMapLink":false,"_EventURL":"","_EventCost":"","_EventCostDescription":"","_EventCurrencySymbol":"","_EventCurrencyCode":"","_EventCurrencyPosition":"","_EventDateTimeSeparator":"","_EventTimeRangeSeparator":"","_EventOrganizerID":[],"_EventVenueID":[],"_OrganizerEmail":"","_OrganizerPhone":"","_OrganizerWebsite":"","_VenueAddress":"","_VenueCity":"","_VenueCountry":"","_VenueProvince":"","_VenueState":"","_VenueZip":"","_VenuePhone":"","_VenueURL":"","_VenueStateProvince":"","_VenueLat":"","_VenueLng":"","_VenueShowMap":false,"_VenueShowMapLink":false,"footnotes":""},"categories":[134],"tags":[162,106,541,55,444,290,48,64,56,132],"yoast_head":"\nNew cannabis research: cancer, type 2 diabetes, autism, fibromyalgia<\/title>\n<meta name=\"description\" content=\"New research suggests cannabis may reduce risk of type 2 diabetes, other studies shed light on fibromyalgia, autism and skin disorders.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cannabishealthnews.co.uk\/2023\/09\/21\/new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New cannabis research: cancer, Type 2 diabetes, autism, fibromyalgia and skin disorders\" \/>\n<meta property=\"og:description\" content=\"New research suggests cannabis may reduce risk of type 2 diabetes, other studies shed light on fibromyalgia, autism and skin disorders.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cannabishealthnews.co.uk\/2023\/09\/21\/new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders\/\" \/>\n<meta property=\"og:site_name\" content=\"Cannabis Health News\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Cannabis-Health-Magazine-1047415772315886\/?ref=bookmarks\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-21T08:35:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-09-21T08:40:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cannabishealthnews.co.uk\/wp-content\/uploads\/2023\/09\/Untitled-design-2023-09-19T172320.722.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"700\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Sarah Sinclair\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@https:\/\/twitter.com\/sarahlsinclair_\" \/>\n<meta name=\"twitter:site\" content=\"@cannabishnews\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sarah Sinclair\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/cannabishealthnews.co.uk\/2023\/09\/21\/new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/cannabishealthnews.co.uk\/2023\/09\/21\/new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders\/\"},\"author\":{\"name\":\"Sarah Sinclair\",\"@id\":\"https:\/\/35.246.32.45\/#\/schema\/person\/a98debc354a259e7c4d1ddd96afa8a09\"},\"headline\":\"New cannabis research: cancer, Type 2 diabetes, autism, fibromyalgia and skin disorders\",\"datePublished\":\"2023-09-21T08:35:26+00:00\",\"dateModified\":\"2023-09-21T08:40:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cannabishealthnews.co.uk\/2023\/09\/21\/new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders\/\"},\"wordCount\":724,\"publisher\":{\"@id\":\"https:\/\/35.246.32.45\/#organization\"},\"image\":{\"@id\":\"https:\/\/cannabishealthnews.co.uk\/2023\/09\/21\/new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cannabishealthnews.co.uk\/wp-content\/uploads\/2023\/09\/Untitled-design-2023-09-19T172320.722.png\",\"keywords\":[\"autism\",\"Cancer\",\"cannabinoids\",\"Cannabis\",\"CBD skincare\",\"diabetes\",\"Featured\",\"Fibromyalgia\",\"Research\",\"science\"],\"articleSection\":[\"Science\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cannabishealthnews.co.uk\/2023\/09\/21\/new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders\/\",\"url\":\"https:\/\/cannabishealthnews.co.uk\/2023\/09\/21\/new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders\/\",\"name\":\"New cannabis research: cancer, type 2 diabetes, autism, fibromyalgia\",\"isPartOf\":{\"@id\":\"https:\/\/35.246.32.45\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cannabishealthnews.co.uk\/2023\/09\/21\/new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cannabishealthnews.co.uk\/2023\/09\/21\/new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cannabishealthnews.co.uk\/wp-content\/uploads\/2023\/09\/Untitled-design-2023-09-19T172320.722.png\",\"datePublished\":\"2023-09-21T08:35:26+00:00\",\"dateModified\":\"2023-09-21T08:40:15+00:00\",\"description\":\"New research suggests cannabis may reduce risk of type 2 diabetes, other studies shed light on fibromyalgia, autism and skin disorders.\",\"breadcrumb\":{\"@id\":\"https:\/\/cannabishealthnews.co.uk\/2023\/09\/21\/new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cannabishealthnews.co.uk\/2023\/09\/21\/new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/cannabishealthnews.co.uk\/2023\/09\/21\/new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders\/#primaryimage\",\"url\":\"https:\/\/cannabishealthnews.co.uk\/wp-content\/uploads\/2023\/09\/Untitled-design-2023-09-19T172320.722.png\",\"contentUrl\":\"https:\/\/cannabishealthnews.co.uk\/wp-content\/uploads\/2023\/09\/Untitled-design-2023-09-19T172320.722.png\",\"width\":1200,\"height\":700},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cannabishealthnews.co.uk\/2023\/09\/21\/new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/35.246.32.45\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Science\",\"item\":\"https:\/\/35.246.32.45\/category\/science\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"New cannabis research: cancer, Type 2 diabetes, autism, fibromyalgia and skin disorders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/35.246.32.45\/#website\",\"url\":\"https:\/\/35.246.32.45\/\",\"name\":\"Cannabis Health News\",\"description\":\"Covering medical cannabis from every angle\",\"publisher\":{\"@id\":\"https:\/\/35.246.32.45\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/35.246.32.45\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/35.246.32.45\/#organization\",\"name\":\"Cannabis Health\",\"url\":\"https:\/\/35.246.32.45\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/35.246.32.45\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cannabishealthnews.co.uk\/wp-content\/uploads\/2020\/07\/CH-Logo-ICON.png\",\"contentUrl\":\"https:\/\/cannabishealthnews.co.uk\/wp-content\/uploads\/2020\/07\/CH-Logo-ICON.png\",\"width\":168,\"height\":164,\"caption\":\"Cannabis Health\"},\"image\":{\"@id\":\"https:\/\/35.246.32.45\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Cannabis-Health-Magazine-1047415772315886\/?ref=bookmarks\",\"https:\/\/x.com\/cannabishnews\",\"https:\/\/www.instagram.com\/cannabishealthmagazine\/?hl=en\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/35.246.32.45\/#\/schema\/person\/a98debc354a259e7c4d1ddd96afa8a09\",\"name\":\"Sarah Sinclair\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/35.246.32.45\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/6d71f98750925725c2633c3671cd2558?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/6d71f98750925725c2633c3671cd2558?s=96&d=mm&r=g\",\"caption\":\"Sarah Sinclair\"},\"description\":\"Sarah Sinclair is a respected cannabis journalist writing on subjects related to science, medicine, research, health and wellness. She is managing editor of Cannabis Health, the UK\u2019s leading title covering medical cannabis and CBD, and sister titles, Cannabis Wealth and Psychedelic Health. Sarah has an NCTJ journalism qualification and an MA in Journalism from the University of Sunderland. Sarah has over six years experience working on newspapers, magazines and digital-first titles, the last two of which have been in the cannabis sector. She has also completed training through the Medical Cannabis Clinicians Society securing a certificate in Medical Cannabis Explained. She is a member of PLEA\u2019s (Patient-Led Engagement for Access) advisory board, has hosted several webinars on cannabis and women's health and has moderated at industry events such as Cannabis Europa. Sarah Sinclair is the editor of Cannabis Health. Got a story? Email sarah@handwmedia.co.uk \/ Follow us on Twitter: @CannabisHNews \/ Instagram: @cannabishealthmag\",\"sameAs\":[\"https:\/\/cannabishealthnews.co.uk\",\"https:\/\/www.instagram.com\/sarahlsinclair_\/\",\"https:\/\/www.linkedin.com\/in\/sarahlsinclair\/\",\"https:\/\/x.com\/https:\/\/twitter.com\/sarahlsinclair_\"],\"url\":\"https:\/\/cannabishealthnews.co.uk\/author\/sarah_sinclair\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"New cannabis research: cancer, type 2 diabetes, autism, fibromyalgia","description":"New research suggests cannabis may reduce risk of type 2 diabetes, other studies shed light on fibromyalgia, autism and skin disorders.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cannabishealthnews.co.uk\/2023\/09\/21\/new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders\/","og_locale":"en_GB","og_type":"article","og_title":"New cannabis research: cancer, Type 2 diabetes, autism, fibromyalgia and skin disorders","og_description":"New research suggests cannabis may reduce risk of type 2 diabetes, other studies shed light on fibromyalgia, autism and skin disorders.","og_url":"https:\/\/cannabishealthnews.co.uk\/2023\/09\/21\/new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders\/","og_site_name":"Cannabis Health News","article_publisher":"https:\/\/www.facebook.com\/Cannabis-Health-Magazine-1047415772315886\/?ref=bookmarks","article_published_time":"2023-09-21T08:35:26+00:00","article_modified_time":"2023-09-21T08:40:15+00:00","og_image":[{"width":1200,"height":700,"url":"https:\/\/cannabishealthnews.co.uk\/wp-content\/uploads\/2023\/09\/Untitled-design-2023-09-19T172320.722.png","type":"image\/png"}],"author":"Sarah Sinclair","twitter_card":"summary_large_image","twitter_creator":"@https:\/\/twitter.com\/sarahlsinclair_","twitter_site":"@cannabishnews","twitter_misc":{"Written by":"Sarah Sinclair","Estimated reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/cannabishealthnews.co.uk\/2023\/09\/21\/new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders\/#article","isPartOf":{"@id":"https:\/\/cannabishealthnews.co.uk\/2023\/09\/21\/new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders\/"},"author":{"name":"Sarah Sinclair","@id":"https:\/\/35.246.32.45\/#\/schema\/person\/a98debc354a259e7c4d1ddd96afa8a09"},"headline":"New cannabis research: cancer, Type 2 diabetes, autism, fibromyalgia and skin disorders","datePublished":"2023-09-21T08:35:26+00:00","dateModified":"2023-09-21T08:40:15+00:00","mainEntityOfPage":{"@id":"https:\/\/cannabishealthnews.co.uk\/2023\/09\/21\/new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders\/"},"wordCount":724,"publisher":{"@id":"https:\/\/35.246.32.45\/#organization"},"image":{"@id":"https:\/\/cannabishealthnews.co.uk\/2023\/09\/21\/new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders\/#primaryimage"},"thumbnailUrl":"https:\/\/cannabishealthnews.co.uk\/wp-content\/uploads\/2023\/09\/Untitled-design-2023-09-19T172320.722.png","keywords":["autism","Cancer","cannabinoids","Cannabis","CBD skincare","diabetes","Featured","Fibromyalgia","Research","science"],"articleSection":["Science"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/cannabishealthnews.co.uk\/2023\/09\/21\/new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders\/","url":"https:\/\/cannabishealthnews.co.uk\/2023\/09\/21\/new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders\/","name":"New cannabis research: cancer, type 2 diabetes, autism, fibromyalgia","isPartOf":{"@id":"https:\/\/35.246.32.45\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cannabishealthnews.co.uk\/2023\/09\/21\/new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders\/#primaryimage"},"image":{"@id":"https:\/\/cannabishealthnews.co.uk\/2023\/09\/21\/new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders\/#primaryimage"},"thumbnailUrl":"https:\/\/cannabishealthnews.co.uk\/wp-content\/uploads\/2023\/09\/Untitled-design-2023-09-19T172320.722.png","datePublished":"2023-09-21T08:35:26+00:00","dateModified":"2023-09-21T08:40:15+00:00","description":"New research suggests cannabis may reduce risk of type 2 diabetes, other studies shed light on fibromyalgia, autism and skin disorders.","breadcrumb":{"@id":"https:\/\/cannabishealthnews.co.uk\/2023\/09\/21\/new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cannabishealthnews.co.uk\/2023\/09\/21\/new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/cannabishealthnews.co.uk\/2023\/09\/21\/new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders\/#primaryimage","url":"https:\/\/cannabishealthnews.co.uk\/wp-content\/uploads\/2023\/09\/Untitled-design-2023-09-19T172320.722.png","contentUrl":"https:\/\/cannabishealthnews.co.uk\/wp-content\/uploads\/2023\/09\/Untitled-design-2023-09-19T172320.722.png","width":1200,"height":700},{"@type":"BreadcrumbList","@id":"https:\/\/cannabishealthnews.co.uk\/2023\/09\/21\/new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/35.246.32.45\/"},{"@type":"ListItem","position":2,"name":"Science","item":"https:\/\/35.246.32.45\/category\/science\/"},{"@type":"ListItem","position":3,"name":"New cannabis research: cancer, Type 2 diabetes, autism, fibromyalgia and skin disorders"}]},{"@type":"WebSite","@id":"https:\/\/35.246.32.45\/#website","url":"https:\/\/35.246.32.45\/","name":"Cannabis Health News","description":"Covering medical cannabis from every angle","publisher":{"@id":"https:\/\/35.246.32.45\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/35.246.32.45\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/35.246.32.45\/#organization","name":"Cannabis Health","url":"https:\/\/35.246.32.45\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/35.246.32.45\/#\/schema\/logo\/image\/","url":"https:\/\/cannabishealthnews.co.uk\/wp-content\/uploads\/2020\/07\/CH-Logo-ICON.png","contentUrl":"https:\/\/cannabishealthnews.co.uk\/wp-content\/uploads\/2020\/07\/CH-Logo-ICON.png","width":168,"height":164,"caption":"Cannabis Health"},"image":{"@id":"https:\/\/35.246.32.45\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Cannabis-Health-Magazine-1047415772315886\/?ref=bookmarks","https:\/\/x.com\/cannabishnews","https:\/\/www.instagram.com\/cannabishealthmagazine\/?hl=en"]},{"@type":"Person","@id":"https:\/\/35.246.32.45\/#\/schema\/person\/a98debc354a259e7c4d1ddd96afa8a09","name":"Sarah Sinclair","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/35.246.32.45\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/6d71f98750925725c2633c3671cd2558?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6d71f98750925725c2633c3671cd2558?s=96&d=mm&r=g","caption":"Sarah Sinclair"},"description":"Sarah Sinclair is a respected cannabis journalist writing on subjects related to science, medicine, research, health and wellness. She is managing editor of Cannabis Health, the UK\u2019s leading title covering medical cannabis and CBD, and sister titles, Cannabis Wealth and Psychedelic Health. Sarah has an NCTJ journalism qualification and an MA in Journalism from the University of Sunderland. Sarah has over six years experience working on newspapers, magazines and digital-first titles, the last two of which have been in the cannabis sector. She has also completed training through the Medical Cannabis Clinicians Society securing a certificate in Medical Cannabis Explained. She is a member of PLEA\u2019s (Patient-Led Engagement for Access) advisory board, has hosted several webinars on cannabis and women's health and has moderated at industry events such as Cannabis Europa. Sarah Sinclair is the editor of Cannabis Health. Got a story? Email sarah@handwmedia.co.uk \/ Follow us on Twitter: @CannabisHNews \/ Instagram: @cannabishealthmag","sameAs":["https:\/\/cannabishealthnews.co.uk","https:\/\/www.instagram.com\/sarahlsinclair_\/","https:\/\/www.linkedin.com\/in\/sarahlsinclair\/","https:\/\/x.com\/https:\/\/twitter.com\/sarahlsinclair_"],"url":"https:\/\/cannabishealthnews.co.uk\/author\/sarah_sinclair\/"}]}},"_links":{"self":[{"href":"https:\/\/cannabishealthnews.co.uk\/wp-json\/wp\/v2\/posts\/28802"}],"collection":[{"href":"https:\/\/cannabishealthnews.co.uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannabishealthnews.co.uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannabishealthnews.co.uk\/wp-json\/wp\/v2\/users\/17"}],"replies":[{"embeddable":true,"href":"https:\/\/cannabishealthnews.co.uk\/wp-json\/wp\/v2\/comments?post=28802"}],"version-history":[{"count":5,"href":"https:\/\/cannabishealthnews.co.uk\/wp-json\/wp\/v2\/posts\/28802\/revisions"}],"predecessor-version":[{"id":28825,"href":"https:\/\/cannabishealthnews.co.uk\/wp-json\/wp\/v2\/posts\/28802\/revisions\/28825"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cannabishealthnews.co.uk\/wp-json\/wp\/v2\/media\/28822"}],"wp:attachment":[{"href":"https:\/\/cannabishealthnews.co.uk\/wp-json\/wp\/v2\/media?parent=28802"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannabishealthnews.co.uk\/wp-json\/wp\/v2\/categories?post=28802"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannabishealthnews.co.uk\/wp-json\/wp\/v2\/tags?post=28802"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}